EU agency says AZ clot risk should be listed as 'very rare'

Covid vaccine

A man receives a dose of the Oxford/AstraZeneca vaccine at an outpatient clinic in Kiev on April 7, 2021. The EU's medicines regulator said Wednesday that blood clots should be listed as a rare side effect of the AstraZeneca vaccine.

Photo credit: Genya Savilov | AFP

The Hague

Welcome!

You're all set to enjoy unlimited Prime content.